Concepedia

Publication | Closed Access

Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial

DOI

332

Citations

28

References

2013

Year

William Greenhalf, Paula Ghaneh, John P. Neoptolemos, Daniel H. Palmer, Trevor F. Cox, Richard F. Lamb, Elizabeth O. Garner, Fiona Campbell, John R. Mackey, Eithne Costello,
JNCI Journal of the National Cancer Institute

Abstract

Subject to prospective validation, gemcitabine should not be used for patients with low tumor hENT1 expression.

References

YearCitations

Page 1